Black Rock Inc. Enveric Biosciences, Inc. Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.22 - $13.1 $1.9 Million - $5.9 Million	-450,494 Closed	0 $0
Q2 2022 Aug 12, 2022	SELL	$8.8 - $16.2 $427,187 - $786,412	-48,544 Reduced 9.73%	450,494 $97,000
Q1 2022 May 12, 2022	SELL	$12.5 - $52.0 $29,250 - $121,680	-2,340 Reduced 0.47%	499,038 $165,000
Q4 2021 Feb 10, 2022	BUY	$46.5 - $104.0 $60,450 - $135,200	1,300 Added 0.26%	501,378 $466,000
Q3 2021 Nov 09, 2021	SELL	$80.5 - $175.0 $757,022 - $1.65 Million	-9,404 Reduced 1.85%	500,078 $1.04 Million
Q2 2021 Aug 11, 2021	BUY	$95.0 - $156.5 $48.4 Million - $79.7 Million	509,482 New	509,482 $1.21 Million

Ticker ENVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,078,270
Market Cap $1.04M
Description
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.